Gene · 3587
Papers3,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,503
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gastrointestinal disorders and intestinal bacteria: Advances in research and applications in therapy. | Front Med (Lausanne) | 2022 | 36825261 | PubTator, text mining | PubMed |
| Butyrate producers, "The Sentinel of Gut": Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. | Front Microbiol | 2022 | 36713166 | PubTator, text mining | PubMed |
| Distinct stimulus-dependent neutrophil dynamics revealed by real-time imaging of intestinal mucosa after acute injury. | PNAS Nexus | 2022 | 36712325 | PubTator, text mining | PubMed |
| Akkermansia deficiency and mucin depletion are implicated in intestinal barrier dysfunction as earlier event in the development of inflammation in interleukin-10-deficient mice. | Front Microbiol | 2022 | 36699599 | PubTator, text mining | PubMed |
| Shared gene characteristics and molecular mechanisms of macrophages M1 polarization in calcified aortic valve disease. | Front Cardiovasc Med | 2022 | 36684607 | PubTator, text mining | PubMed |
| The Latest Approach of Immunotherapy with Endosomal TLR Agonists Improving NK Cell Function: An Overview. | Biomedicines | 2022 | 36672572 | PubTator, text mining | PubMed |
| Strategies of Macrophages to Maintain Bone Homeostasis and Promote Bone Repair: A Narrative Review. | J Funct Biomater | 2022 | 36662065 | PubTator, text mining | PubMed |
| Identifying effective diagnostic biomarkers and immune infiltration features in chronic kidney disease by bioinformatics and validation. | Front Pharmacol | 2022 | 36642989 | PubTator, text mining | PubMed |
| S100A8 and S100A12 Proteins as Biomarkers of High Disease Activity in Patients with Rheumatoid Arthritis That Can Be Regulated by Epigenetic Drugs. | Int J Mol Sci | 2022 | 36614150 | PubTator, text mining | PubMed |
| Structural Studies of Expressed tIK, Anti-Inflammatory Peptide. | Int J Mol Sci | 2022 | 36614076 | PubTator, text mining | PubMed |
| Immune activation of characteristic gut mycobiota Kazachstania pintolopesii on IL-23/IL-17R signaling in ankylosing spondylitis. | Front Cell Infect Microbiol | 2022 | 36605130 | PubTator, text mining | PubMed |
| The emerging roles of TLR and cGAS signaling in tumorigenesis and progression of ovarian cancer. | Front Pharmacol | 2022 | 36588690 | PubTator, text mining | PubMed |
| Integrated molecular analyses of an interferon-γ based subtype with regard to outcome, immune characteristics, and immunotherapy in bladder cancer and experimental verification. | Heliyon | 2022 | 36582677 | PubTator, text mining | PubMed |
| Precision medicine: The use of tailored therapy in primary immunodeficiencies. | Front Immunol | 2022 | 36569887 | PubTator, text mining | PubMed |
| High expression of B4GALT1 is associated with poor prognosis in acute myeloid leukemia. | Front Genet | 2022 | 36568388 | PubTator, text mining | PubMed |
| Development of Ag-ZnO/AgO Nanocomposites Effectives for Leishmania braziliensis Treatment. | Pharmaceutics | 2022 | 36559136 | PubTator, text mining | PubMed |
| Effects of Helicobacter pylori and Nitrate-Reducing Bacteria Coculture on Cells. | Microorganisms | 2022 | 36557748 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update. | Genes (Basel) | 2022 | 36553655 | PubTator, text mining | PubMed |
| Polypharmacological Cell-Penetrating Peptides from Venomous Marine Animals Based on Immunomodulating, Antimicrobial, and Anticancer Properties. | Mar Drugs | 2022 | 36547910 | PubTator, text mining | PubMed |
| Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis. | Front Immunol | 2022 | 36532018 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3587/papers?page=26